A -- Centralized Service Facility for Mouse Testing of Candidate SMA Compounds

The SMA Project is preparing to release a Request for Proposals for a centralized service facility dedicated to mouse testing of candidate compounds targeting Spinal Muscular Atrophy (SMA). This initiative supports the accelerated development of treatments for SMA, a severe neurodegenerative disease affecting children. Proposals will be accepted from any responsible offeror and must be submitted within at least four weeks following the RFP release. Interested parties are encouraged to join the SMA Project ListServ to receive immediate notifications upon release of the RFP, with additional announcements to be posted concurrently on FedBizOpps and the SMA Project website. The program is overseen by the National Institute for Neurological Disorders and Stroke (NINDS) and is managed in partnership with Science Applications International Corporation (SAIC). The focus is on milestone-driven research aimed at advancing therapeutics for SMA. The solicitation, identified by JL-19704-1, was posted in late June 2004 and will provide access to proposal documents through the Open Solicitations page on the SMA Project website. This opportunity facilitates collaboration among researchers and organizations invested in addressing SMA through innovative compound testing in a centralized mouse model facility.